Publications

(Displaying in Reverse Chronological Order)

  1. Research
  2. Publications
  3. Publications
2191
Singh S, Bhutani H and Prasad B. Refocus on the Stability and Quality of Anti-TB Formulations International Journal of Tuberculosis and Lung Disease 2006, 10, 1064-1065.
2192
Singh S, Kaur G, Chakraborti AK, Jain RK and Banerjee UC. Study of the experimental conditions for the lipase production by a newly isolated strain of Pseudomonas aeruginosa for the enantioselective hydrolysis of (+/-)-methyl trans-3(4-methoxyphenyl) glycidate Bioprocess and Biosystems Engineering 2006, 28, 341-348.
2193
Singh S, Singh B, Bahuguna R, Wadhwa L and Saxena R. Stress degradation studies on ezetimibe and development of a validated stability-indicating HPLC assay Journal of Pharmaceutical and Biomedical Analysis 2006, 41, 1037-1040.
2194
Singh SK, Dessalew N and Bharatam PV. 3D-QSAR CoMFA study on indenopyrazole derivatives as cyclin dependent kinase 4 (CDK4) and cyclin dependent kinase 2 (CDK2) inhibitors European Journal of Medicinal Chemistry 2006, 41, 1310-1319.
2195
Soni P and Banerjee UC. Enantioselective reduction of acetophenone and its derivatives with a new yeast isolate Candida tropicalis PBR-2 MTCC 5158 Biotechnology Journal 2006, 1, 80-85.
2196
Soni P, Prasad GS and Banerjee UC. Optimization of physicochemical parameters for the enhancement of carbonyl reductase production by Candida viswanathii Bioprocess and Biosystems Engineering 2006, 29, 149-156.
2197
Sukhpreet and Tiwari P. Role of Medicine Information in the Pharmaceutical Industry Indian Journal of Pharmaceutical Sciences 2006, 68, 801-804.
2198
Tamta H, Kalra S and Mukhopadhyay AK. Biochemical characterization of some pyrazolopyrimidine-based inhibitors of xanthine oxidase Biochemistry (Moscow) 2006, 71, S49-S54..
2199
Tiwari P and Sukhpreet. An investigational study of pharmaceutical care issues in individual patients in a hospital setting International Journal of Risk & Safety in Medicine 2006, 18, 99-105.
2200
Vats P and Banerjee UC. Catalytic characterization of phytase (myo-inositolhexakisphosphate phosphohydrolase) from Aspergillus niger van Teighem: Glycosylation pattern, kinetics and molecular properties Enzyme and Microbial Technology 2006, 39, 596-600.
2201
Vats RK. Palladium(II) acetate [Pd(OAc)2]: A versatile catalyst Synlett 2006, 2006, 329-330.
2202
Verma NK and Dey CS. The anti-leishmanial drug miltefosine causes insulin resistance in skeletal muscle cells in vitro Diabetologia 2006, 49, 1656-1660.
2203
Viswanad B, Srinivasan K, Kaul CL, and Ramarao P. Effect of Tempol on Altered Angiotensin II and Acetylcholine-Mediated Vascular Responses in Thoracic Aorta Isolated from Rats with Insulin Resistance Pharmacological Research 2006, 53, 209-215.
2204
Agarwal S, Sharma S, Agrawal V and Roy N. Caloric restriction augments ROS defense in S cerevisiae, by a Sir2p independent mechanism Free Radical Research 2005, 39, 55-62.
2205
Agrawal S and Panchagnula R. Implication of biopharmaceutics and pharmacokinetics of rifampicin in variable bioavailability from solid oral dosage forms Biopharmaceutics and Drug Disposition 2005, 26, 321-334.
Information: Duration to be uploaded/incorporated on archival site after the completion of process is 12 months.

2627|147|15